| Useful Advices |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Business > Sales Teleselling > Anybody Can Write A Script! |
|
Useful Advices - Anybody Can Write A Script!
I was having a conversation with a couple of prospects the other day. The afternoon sunl According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product ight cascaded through their ground floor conference room, but it was the only source of i ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in llumination in the place. Otherwise, we could have been in a cave, tens of thousands of lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. years ago—this is how primitive the conversation was. After I assessed the lack of quali here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe y in the script they’re using for handling inbound sales prospects, one of them snapped: d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro “I can get anybody to write a script!” Of course, that’s exactly what you did. You got ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc just anybody to write the current version, and that’s why: (1) It is not producing resul easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi s, enough conversions of inquiries to appointments; (2) Your people aren’t using it, bec nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically ause it doesn’t flow, like natural conversation; and (3) You’re shopping for professiona and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ l help, right now. If the script was good, or you were effective at putting it to work, a ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi d managing your folks so they performed it consistently and well, I wouldn’t be sitting h ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a ere, right? Before you get the idea that all my prospects are stupid, let me say quite c dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod learly, they aren’t. Usually, they’re quite successful, and their problem isn’t intellige cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin nce. It’s DISRESPECT. As my professor, famed management guru Peter F. Drucker said: “We tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen won’t succeed in any area that we don’t respect.” Frame these words! Most people disres t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel pect customer service, telemarketing, and sales work; largely, because they don’t underst ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust and it, and they think it’s easy, entailing not true ability, but a “knack.” Unfortunate y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products y, there isn’t a school that you can attend that will teach respect. This is supposed to . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de happen in one’s upbringing, along with its behavioral manifestation: good manners. As lo elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip ng as people disrespect the work I’ve described above, they’ll be powerless to improve it tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:Comparing Stock Trading to FOREX Trading Make 2007 Your Breakout Year - The One Step That Can Make It Happen
|